Protalix BioTherapeutics, Inc.
PLX- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001006281
No open-market purchases or sales by Protalix BioTherapeutics, Inc. insiders were filed in the last 90 days; 101 institutions reported holding it in 13F filings for Q2 2026, worth $33.7M in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Protalix BioTherapeutics, Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Of which not filed for Q4 2025 | Q4 2025 | Change |
|---|---|---|---|---|
| Holders | 77 | 1 | 83 | +7 |
| Shares | 13.9M | 70.4K | 14.9M | +1.05M (+7.6%) |
| Value | $30.9M | $152.1K | $26.8M | −$3.93M (−12.8%) |
1 institution that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (12)
Institutions that held Protalix BioTherapeutics, Inc. at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jane Street Group, LLC | 289,917 | $521.9K | 0.00% |
| Round Rock Advisors, LLC | 155,102 | $279.2K | 0.04% |
| Lazard Asset Management LLC | 71,393 | $128.5K | 0.00% |
| HRT Financial LP | 64,610 | $116.0K | 0.00% |
| Two Sigma Securities, LLC | 39,811 | $71.7K | 0.01% |
| Smartleaf Asset Management LLC | 25,975 | $45.2K | 0.00% |
| State of Alaska, Department of Revenue | 21,831 | $39.0K | 0.00% |
| Marshall Wace, LLP | 19,079 | $34.3K | 0.00% |
| SG Americas Securities, LLC | 17,155 | $31.0K | 0.00% |
| R Squared Ltd | 14,632 | $26.3K | 0.01% |
| Equitable Holdings, Inc. | 11,150 | $20.1K | 0.00% |
| GAMMA Investing LLC | 355 | $639 | 0.00% |
Sold out (5)
Institutions that held Protalix BioTherapeutics, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| State of Wyoming | 39,018 | $86.6K |
| Virtu Financial LLC | 16,530 | $37.0K |
| Simplex Trading, LLC | 2,942 | $6.00K |
| Truvestments Capital LLC | 2,458 | $5.46K |
| Steward Partners Investment Advisory, LLC | 25 | $56 |
Not filed for Q4 2025 yet (1)
Institutions that held Protalix BioTherapeutics, Inc. at the end of Q3 2025 and haven't filed a 13F for Q4 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Wolverine Trading, LLC | 70,394 | $152.1K |